Sökning: "Marcus Lind"
Visar resultat 1 - 5 av 7 avhandlingar innehållade orden Marcus Lind.
1. Determinants of adverse events during oral anticoagulant treatment
Sammanfattning : Treament with oral anticoagulation is highly effective in reducing the burden of thromboembolic complications in several clinical conditions. The number of patients receiving oral anticoagulation is growing steadily. InSwedenabout 1.5 percent of the population receives treatment. LÄS MER
2. Glycaemic control: evaluation of HbA1c as a risk factor and the effect of modern insulins in clinical practice
Sammanfattning : One of the ultimate goals of diabetes care is to minimise diabetic complications. When evaluating insulins it is important to understand what extent of improvements in glycaemic control is clinically relevant in preventing diabetic complications. LÄS MER
3. Risk markers and incidence of atrial fibrillation in northern Sweden
Sammanfattning : Background: Atrial fibrillation (AF) is the most common clinically significant arrythmia with a prevalence of approximately 3% in the general population. Less is known about the incidence of AF. In order to reduce the incidence of AF, it is of essence to identify modifiable risk factors for the disease. LÄS MER
4. Biomarkers and risk of intracerebral hemorrhage : population-based studies in northern Sweden
Sammanfattning : BackgroundIntracerebral hemorrhage (ICH) is a disease associated with a high morbidity and mortality and treatment options for the condition are limited. Even though an ICH event usually comes as a surprise to the affected individual, pathogenetic processes often have occurred before the sudden ICH event and may have preceded disease onset by years. LÄS MER
5. Epidemiology of venous thromboembolism with focus on risk markers
Sammanfattning : Background: Venous thromboembolism (VTE) is a vascular disease with an incidence of approximately 140 cases per 100,000 person-years in adults. The incidence of VTE has increased over the last decades, and more than 20% of affected individuals die in the first year after diagnosis. LÄS MER